In vivo Scientist, Cell Therapy Functional Assessment
ExternalPrepare for this interview
EliteAI-generated questions, company research, and talking points tailored to this role
About the role
BeOne is a global oncology company that is discovering and developing innovative treatments that are more affordable and accessible to cancer patients worldwide. With a broad portfolio, we are expediting development of our diverse pipeline of novel therapeutics through our internal capabilities and collaborations. We are committed to radically improving access to medicines for far more patients who need them. Our growing global team of more than 10,000 colleagues spans five continents, with administrative offices in Basel, Beijing, and Cambridge, U.S. To learn more about BeOne , please visit www.beonemedicines.com and follow us on LinkedIn and X (formerly known as Twitter). BeOne continues to grow at a rapid pace with challenging and exciting opportunities for experienced professionals. When considering candidates, we look for scientific and business professionals who are highly motivated, collaborative, and most importantly, share our passionate interest in fighting cancer. Job Description: BeOne is growing, and we are seeking passionate scientists who are eager to take on new challenges and exciting opportunities. The Functional Assessment of Cell Therapy group at BeOne is looking for a motivated scientist who is enthusiastic about the potential of engineered immune cells in cancer treatment and interested in contributing to drug development through preclinical research. In this role, you will work closely with Research Investigators to support proof-of-concept studies in rodent models and help build in vivo functional assessment platforms that aim to inform clinical translation of cell-based therapies. The Functional Assessment Group conducts integrated in vitro and in vivo research, evaluating drug potency, pharmacology, biomarkers, histology, toxicology, and other key parameters that support the safety and efficacy of our therapeutic programs.